FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890846394> ?p ?o ?g. }

• W2890846394 endingPage "174" @default.
• W2890846394 startingPage "168" @default.
• W2890846394 abstract "Colorectal cancer (CRC) is one of the leading causes of cancer related-deaths. The risk of development of CRC is complex and multifactorial, and includes disruption of homeostasis of the intestinal epithelial layer mediated though dysregulations of tumor suppressing/promoting signaling pathways. Guanylate cyclase 2C (GUCY2C), a membrane-bound guanylate cyclase receptor, is present in the apical membranes of intestinal epithelial cells and maintains homeostasis. GUCY2C is activated upon binding of paracrine hormones (guanylin and uroguanylin) that lead to formation of cyclic GMP from GTP and activation of downstream signaling pathways that are associated with normal homeostasis. Dysregulation/suppression of the GUCY2C-mediated signaling promotes CRC tumorigenesis. High-calorie diet-induced obesity is associated with deficiency of guanylin expression and silencing of GUCY2C-signaling in colon epithelial cells, leading to tumorigenesis. Thus, GUCY2C agonists, such as linaclotide, exhibit considerable role in preventing CRC tumorigenesis. However, phosphodiesterases (PDEs) are elevated in intestinal epithelial cells during CRC tumorigenesis and block GUCY2C-mediated signaling by degrading cyclic GMP to 5`-GMP. PDE5-specific inhibitors, such as sildenafil, show considerable anti-tumorigenic potential against CRC by amplifying the GUCY2C/cGMP signaling pathway, but cannot achieve complete anti-tumorigenic effects. Hence, dual targeting the elevation of cGMP by providing paracrine hormone stimuli to GUCY2C and by inhibition of PDEs may be a better strategy for CRC prevention than alone. This review delineates the involvement of the GUCY2C/cGMP/PDEs signaling pathway in the homeostasis of intestinal epithelial cells. Further, the events are associated with dysregulation of this pathway during CRC tumorigenesis are also discussed. In addition, current updates on targeting the GUCY2C/cGMP/PDEs pathway with GUCY2C agonists and PDEs inhibitors for CRC prevention and treatment are described in detail." @default.
• W2890846394 created "2018-09-27" @default.
• W2890846394 creator A5008384414 @default.
• W2890846394 creator A5009422422 @default.
• W2890846394 creator A5039291412 @default.
• W2890846394 creator A5057380912 @default.
• W2890846394 creator A5058818623 @default.
• W2890846394 creator A5060150700 @default.
• W2890846394 creator A5065952143 @default.
• W2890846394 creator A5082289517 @default.
• W2890846394 creator A5091411272 @default.
• W2890846394 date "2019-06-01" @default.
• W2890846394 modified "2023-10-16" @default.
• W2890846394 title "Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention" @default.
• W2890846394 cites W1861001175 @default.
• W2890846394 cites W1964680364 @default.
• W2890846394 cites W1980647755 @default.
• W2890846394 cites W1993342961 @default.
• W2890846394 cites W1997459488 @default.
• W2890846394 cites W1997826749 @default.
• W2890846394 cites W2010867021 @default.
• W2890846394 cites W2015336843 @default.
• W2890846394 cites W2023878144 @default.
• W2890846394 cites W2030502069 @default.
• W2890846394 cites W2032677788 @default.
• W2890846394 cites W2032900031 @default.
• W2890846394 cites W2035454767 @default.
• W2890846394 cites W2037521370 @default.
• W2890846394 cites W2050666864 @default.
• W2890846394 cites W2051703091 @default.
• W2890846394 cites W2057385415 @default.
• W2890846394 cites W2071937135 @default.
• W2890846394 cites W2072880806 @default.
• W2890846394 cites W2075124821 @default.
• W2890846394 cites W2098837345 @default.
• W2890846394 cites W2100910673 @default.
• W2890846394 cites W2102812577 @default.
• W2890846394 cites W2114021843 @default.
• W2890846394 cites W2128304562 @default.
• W2890846394 cites W2131009163 @default.
• W2890846394 cites W2159193222 @default.
• W2890846394 cites W2239183382 @default.
• W2890846394 cites W2319350696 @default.
• W2890846394 cites W2332840931 @default.
• W2890846394 cites W2382192387 @default.
• W2890846394 cites W2406634493 @default.
• W2890846394 cites W2409214054 @default.
• W2890846394 cites W2514302595 @default.
• W2890846394 cites W2515659349 @default.
• W2890846394 cites W2581171286 @default.
• W2890846394 cites W2594373254 @default.
• W2890846394 cites W2607034898 @default.
• W2890846394 cites W2610323470 @default.
• W2890846394 cites W2613112395 @default.
• W2890846394 cites W2621610098 @default.
• W2890846394 cites W2734520132 @default.
• W2890846394 cites W2766970431 @default.
• W2890846394 cites W2782172753 @default.
• W2890846394 cites W2796020321 @default.
• W2890846394 cites W2801331226 @default.
• W2890846394 cites W2978648982 @default.
• W2890846394 doi "https://doi.org/10.1016/j.semcancer.2018.08.011" @default.
• W2890846394 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30189250" @default.
• W2890846394 hasPublicationYear "2019" @default.
• W2890846394 type Work @default.
• W2890846394 sameAs 2890846394 @default.
• W2890846394 citedByCount "19" @default.
• W2890846394 countsByYear W28908463942019 @default.
• W2890846394 countsByYear W28908463942020 @default.
• W2890846394 countsByYear W28908463942021 @default.
• W2890846394 countsByYear W28908463942022 @default.
• W2890846394 countsByYear W28908463942023 @default.
• W2890846394 crossrefType "journal-article" @default.
• W2890846394 hasAuthorship W2890846394A5008384414 @default.
• W2890846394 hasAuthorship W2890846394A5009422422 @default.
• W2890846394 hasAuthorship W2890846394A5039291412 @default.
• W2890846394 hasAuthorship W2890846394A5057380912 @default.
• W2890846394 hasAuthorship W2890846394A5058818623 @default.
• W2890846394 hasAuthorship W2890846394A5060150700 @default.
• W2890846394 hasAuthorship W2890846394A5065952143 @default.
• W2890846394 hasAuthorship W2890846394A5082289517 @default.
• W2890846394 hasAuthorship W2890846394A5091411272 @default.
• W2890846394 hasConcept C121608353 @default.
• W2890846394 hasConcept C126322002 @default.
• W2890846394 hasConcept C128240485 @default.
• W2890846394 hasConcept C134018914 @default.
• W2890846394 hasConcept C170493617 @default.
• W2890846394 hasConcept C502942594 @default.
• W2890846394 hasConcept C555283112 @default.
• W2890846394 hasConcept C62478195 @default.
• W2890846394 hasConcept C63645605 @default.
• W2890846394 hasConcept C71924100 @default.
• W2890846394 hasConcept C7876069 @default.
• W2890846394 hasConcept C86803240 @default.
• W2890846394 hasConcept C95444343 @default.
• W2890846394 hasConceptScore W2890846394C121608353 @default.
• W2890846394 hasConceptScore W2890846394C126322002 @default.
• W2890846394 hasConceptScore W2890846394C128240485 @default.

• next